Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2024 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...
March 06, 2024 08:30 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

HOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology...
February 27, 2024 17:10 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on...
November 20, 2023 16:40 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor...
November 09, 2023 16:30 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the...
November 07, 2023 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Third Quarter 2023 Financial Results

Q3 Revenues of $25.4 millionQ3 Gross Margin of 58.1%Q3 GAAP operating loss of $0.9 million, adjusted operating income $1.8 millionContinued strong operating cash flow drove debt reduction of $8.3...
November 06, 2023 16:30 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience...
October 30, 2023 09:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET

Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
September 18, 2023 08:57 ET | Source: Harvard Bioscience, Inc.; Etisense

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical...
August 08, 2023 07:18 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Second Quarter 2023 Financial Results

Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass.,...